Boosting leukemia-specific T cell responses in patients following stem cell transplantation

DSpace/Manakin Repository

Boosting leukemia-specific T cell responses in patients following stem cell transplantation

Citable link to this page

 

 
Title: Boosting leukemia-specific T cell responses in patients following stem cell transplantation
Author: Burkhardt, Ute E; Wu, Catherine J

Note: Order does not necessarily reflect citation order of authors.

Citation: Burkhardt, Ute E., and Catherine J Wu. 2013. “Boosting leukemia-specific T cell responses in patients following stem cell transplantation.” Oncoimmunology 2 (11): e26587. doi:10.4161/onci.26587. http://dx.doi.org/10.4161/onci.26587.
Full Text & Related Files:
Abstract: Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patients subjected to allogeneic stem cell transplantation are discussed.
Published Version: doi:10.4161/onci.26587
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897523/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879631
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters